GERN FY 2015 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$36M+3054.5% YoY

Gross Profit

$27M73.7% margin

Operating Income

-$559,000-1.5% margin

Net Income

$46,0000.1% margin

EPS (Diluted)

$0.00

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$24M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$149M

Total Liabilities

$7M

Stockholders' Equity

$142M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36M	$1M	+3054.5%
Gross Profit	$27M	-$8M	+445.9%
Operating Income	-$559,000	-$36M	+98.5%
Net Income	$46,000	-$36M	+100.1%